Sp484
PANEL DISCUSSION
Date
May 19, 2024
Presenters
Cedars-Sinai Medical Center
AdventHealth Medical Group at Altamonte Springs
University of Colorado, Rocky Mountain Regional VA
University of California, Irvine
Tracks
Related Products
INTERVALS OF A PLANT-BASED, LOW-CALORIE DIET IMPROVE CLINICAL SYMPTOMS COMPARED WITH USUAL DIET IN PATIENTS INITIATING ADVANCED THERAPIES FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS
Introduction: Diet plays an important role in ulcerative colitis (UC) yet there are no studies examining the role of diet as adjunctive therapy to medication…
YIELD OF MULTIGENE PANEL GERMLINE GENETIC TESTING AMONG THOSE WITH ADVANCED COLORECTAL ADENOMAS
BACKGROUND & AIM: Advanced adenomas (AAs) [≥1cm, villous, or high-grade dysplasia (HGD)] are precursors to colorectal cancer (CRC) and although guidelines support multi-gene panel testing (MGPT) in those with CRC, it is unclear if MGPT should be performed in individuals with CRC precursors…
IBD-RELATED DYSBIOSIS ACTIVATES EPITHELIAL DUOX2 TO CAUSE A LEAKY GUT IN PATIENTS AND ANIMAL MODELS.
BACKGROUND: Inflammatory bowel diseases (IBD) are characterized by dysbiosis, defects in epithelial barrier function, and increased redox stress…
LYNCH SYNDROME (LS) PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) HAVE SIGNIFICANTLY HIGHER INTESTINAL NEOPLASIA RISK THAN LS PATIENTS WITHOUT IBD
Background & Aims: Inflammatory bowel disease (IBD) and Lynch syndrome (LS) are both risk factors for colorectal cancer (CRC), however it is unclear if those with LS+IBD have compounded cancer risk or if they would benefit from more intensive surveillance…
